Is Vascepa Safe with ACE Inhibitors?
Vascepa (icosapent ethyl), a purified EPA omega-3 fatty acid approved for reducing cardiovascular risk, shows no major contraindications or pharmacokinetic interactions with ACE inhibitors like lisinopril or enalapril. Clinical data from the REDUCE-IT trial, which tested Vascepa in patients with cardiovascular disease or risk factors, included those on standard therapies including antihypertensives such as ACE inhibitors, with no signals of increased adverse events from this combination.[1][2]
What Do Drug Interaction Checkers Say?
Tools like Drugs.com and WebMD report no known interactions between icosapent ethyl and common ACE inhibitors. Both are metabolized differently—Vascepa primarily via beta-oxidation, ACE inhibitors via hepatic enzymes like CYP3A4—with minimal overlap. Minor monitoring for bleeding risk applies due to Vascepa's antithrombotic effects, but ACE inhibitors do not amplify this.[3][4]
Potential Risks or Side Effects to Watch
Patients on both may experience additive effects on blood pressure lowering, potentially leading to hypotension in sensitive individuals (e.g., elderly or dehydrated). Vascepa can increase bleeding time slightly, so caution applies if ACE inhibitors are paired with anticoagulants. Common side effects like muscle pain or gout flares from Vascepa remain unchanged. No renal toxicity synergy noted, despite ACE inhibitors' effects on kidneys.[1][5]
Evidence from Clinical Studies
In REDUCE-IT (19,000+ patients), 50%+ used antihypertensives including ACE inhibitors; subgroup analyses confirmed consistent cardiovascular benefits without excess safety issues. Post-marketing data and FDA labeling list no specific ACE inhibitor warnings.[1][2]
What Doctors Recommend
Consult a physician for personalized advice, especially with conditions like heart failure or diabetes where both drugs are common. Routine blood pressure and kidney function checks suffice—no special dosing adjustments needed.[6]
Sources
[1]: FDA Vascepa Label
[2]: NEJM REDUCE-IT Study
[3]: Drugs.com Interaction Checker
[4]: WebMD Vascepa Interactions
[5]: Amarin REDUCE-IT Safety Data
[6]: American Heart Association Guidelines